Question

Ch. 20 Qutz + Done ted in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study thesefengeging antibody, binatumomab, to recrit T ceis to contrel tumer growth. he deta below are cell cunts (1000 per microite) at baseline Cbeginming of the stuty) anc aiter 20 days on blinatumomab for 5 subjects in the study. The difference (after 20 days minus baseline) is the response variable 0.36 0.24 0.12 0.35 1.12 0.77 Baseline After 20 days Difference 0.15 0.13 1.2 1.2 0.37 0.35 0.18 0.14 Dothe data give evidence at the 4 % level that the mean count of T cells is higher after 20 days on binatumomab? 0.001) The test statistic is t . should be positive, so we haveH: Po>0. Perform attest using the differences as your data

Answer 1

Ansater- iventha Dillerenceso14,0.35,2,0.13, 0.77,0.12 we caleuiate ample mean an d skandard deviahion -tram iven daka am ple mean d = E(d) = 0.41166 samtle variance, st - (d-a) D- 5 6-1 test: #1mthesis Ha u70 This is UPre r -lailed -lest S0.47102 s Scanned with CamScanner

signi fi cance levelo.0y egrees 0 4810 2 dis → Rejection c-lieria, Rejection region 's in direc h'unep Alterna H.ve. hy fothesis since lla: u 70, rejection rU1t(s ㄧ-) RejecHon region h been shaded Scanned with CamScanner Cs

0.04 2.190 Decision Since to纟4c, ue--faiIAo reject the nvu hy PO thes's. -1 sniHcance leve te nsice evidence to conclue +ar u is grealer than o ㄣ 。 Scanned with CamScanner